Summit Therapeutics (SMMT) Return on Sales Growth (1y) (2018 - 2023)
Summit Therapeutics (SMMT) Return on Sales Growth (1y) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 0.00 |
| 10 | Summit Therapeutics | 10.55 Bn | 9.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -2,678.00 |
| Mar 31, 2023 | -1,220.00 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | -65.00 |
| Jun 30, 2022 | 372.00 |
| Mar 31, 2022 | 1.00 |
| Dec 31, 2021 | -35.00 |
| Sep 30, 2021 | 83.00 |
| Jun 30, 2021 | -338.00 |
| Mar 31, 2021 | -72.00 |
| Dec 31, 2020 | -74.00 |
| Sep 30, 2020 | -55.00 |
| Mar 31, 2020 | -5.00 |
| Oct 31, 2019 | -45.00 |
| Jul 31, 2019 | -42.00 |
| Oct 31, 2018 | -12.00 |
| Jul 31, 2018 | 1.00 |
| Apr 30, 2018 | 1.00 |